SEARCH

SEARCH BY CITATION

References

  • 1
    Engelich G, Wright DG, Hartshorn KL. Acquired disorders of phagocyte function complicating medical and surgical illnesses. Clin Infect Dis 2001; 33:20408.
  • 2
    Noursadeghi M, Katz DR, Miller RF. HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS. Lancet Infect Dis 2006; 6:794804.
  • 3
    Bandres JC, Trial J, Musher DM et al. Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infection. J Infect Dis 1993; 168:7583.
  • 4
    Pos O, Stevenhagen A, Meenhorst PL et al. Impaired phagocytosis of Staphylococcus aureus by granulocytes and monocytes of AIDS patients. Clin Exp Immunol 1992; 88:238.
  • 5
    Pitrak DL, Bak PM, DeMarais P et al. Depressed neutrophil superoxide production in human immunodeficiency virus infection. J Infect Dis 1993; 167:140610.
  • 6
    Nottet HS, de Graaf L, de Vos NM et al. Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection. J Infect Dis 1993; 168:8491.
  • 7
    Kaplan JE, Benson C, Holmes KH et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58:1207.
  • 8
    Operator's Manual PHAGOTEST. Available at: http://www.icp.ucl.ac.be/mexp/phagotst.pdf (accessed 1 May 2011). Orpegen Pharma GmBH, Heidelberg, Germany.
  • 9
    Operator's Manual BURSTTEST. Available at: http://www.pvi.uni-bonn.de/bursttst.pdf (accessed 1 May 2011). Orpegen Pharma GmBH, Heidelberg, Germany.
  • 10
    Shalekoff S, Tiemessen CT, Gray CM et al. Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 1998; 5:41.
  • 11
    Covelli V, Pece S, Giuliani G et al. Pathogenetic role of phagocytic abnormalities in human virus immunodeficiency infection: possible therapeutical approaches. A review. Immunopharmacol Immunotoxicol 1997; 19:14764.
  • 12
    Pitrak DL. Neutrophil deficiency and dysfunction in HIV-infected patients. Am J Health Syst Pharm 1999; 56 (Suppl. 5):S916.
  • 13
    Crowe SM, Vardaxis NJ, Kent SJ et al. HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J Leukoc Biol 1994; 56:31827.
  • 14
    Monari C, Baldelli F, Pietrella D et al. Monocyte dysfunction in patients with acquired immunodeficiency syndrome (AIDS) versus Cryptococcus neoformans. J Infect 1997; 35:25763.
  • 15
    Koziel H, Eichbaum Q, Kruskal BA et al. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J Clin Invest 1998; 102:133244.
  • 16
    Kedzierska K, Churchill M, Maslin CL et al. Phagocytic efficiency of monocytes and macrophages obtained from Sydney blood bank cohort members infected with an attenuated strain of HIV-1. J Acquir Immune Defic Syndr 2003; 34:44553.
  • 17
    Schafer V, Kreuter J, Rubsamen-Waigmann H et al. Influence of HIV-infection on the phagocytic activity of monocytes/macrophages and granulocytes. Clin Diagn Virol 1994; 1:27987.
  • 18
    Mastroianni CM, Lichtner M, Mengoni F et al. Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients. AIDS 1999; 13:88390.
  • 19
    Brown EJ, Gresham HD. Phagocytosis. In: Paul WE, ed. Fundamental immunology. Philadelphia, PA: Lippincott Williams & Wilkins, 2003:110526.
  • 20
    Kedzierska K, Ellery P, Mak J et al. HIV-1 down-modulates gamma signaling chain of Fc gamma R in human macrophages: a possible mechanism for inhibition of phagocytosis. J Immunol 2002; 168:2895903.
  • 21
    Kedzierska K, Azzam R, Ellery P et al. Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J Clin Virol 2003; 26:24763.
  • 22
    Mazzolini J, Herit F, Bouchet J et al. Inhibition of phagocytosis in HIV-1 infected macrophages relies on Nef-dependent alteration of focal delivery of recycling compartments. Blood 2010; 115:422636.
  • 23
    Ryder MI, Winkler JR, Weinreb RN. Elevated phagocytosis, oxidative burst, and F-actin formation in PMNs from individuals with intraoral manifestations of HIV infection. J Acquir Immune Defic Syndr 1988; 1:34653.